Advancing Precision Medicine Through Strategic Leadership

Haydar Celik, PhD, is the Founder and Principal of the firm, leading with a vision to advance precision medicine through strategic innovation and regulatory excellence. With extensive experience at the FDA and broad exposure to global regulatory frameworks across the diagnostics and pharmaceutical industries, Haydar guides companies and investors through regulatory pathways and aligns innovation with strategic growth.

Focused on the intersection of diagnostics and drug development, he partners with life-science leaders to bring transformative diagnostic, digital-health, and personalized-medicine solutions to market.

Bridging Science, Regulation & Business

A recognized expert in precision medicine, diagnostics, biomarkers, and AI-driven health technologies, Haydar bridges science, regulation, and business to help organizations build sustainable leadership in an evolving healthcare landscape.

His work spans the full innovation ecosystem, from early product strategy and regulatory positioning to evidence generation and market access, advising executive teams and boards in making confident, high-impact decisions.

A Collaborative Approach to Innovation

Known for his collaborative leadership and clear strategic perspective, Haydar champions innovation that is both visionary and grounded in real-world value.

His global outlook and dedication to advancing personalized healthcare continue to shape the future of diagnostics and life-science innovation.

Beyond the Office

Outside work, Haydar enjoys traveling, gardening, spending time outdoors with his family, and exploring philosophy and the intersection between science and human experience.